+20.1%
GSK vs RPRX
+65.1%
-44.9%
-19.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RPRX | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | -0.2% | +0.3% | +0.1% |
| 7D | -3.5% | -8.4% | +4.8% | +0.6% |
| 30D | -3.4% | -0.6% | -2.8% | -3.2% |
| 3M | -8.1% | +6.4% | -14.6% | -11.0% |
| 6M | -11.1% | +26.6% | -37.7% | -20.7% |
| YTD | +0.7% | +53.8% | -53.0% | -15.8% |
| 1Y | +20.1% | +62.8% | -42.7% | -1.6% |
| All | +20.1% | +65.1% | -44.9% | -1.6% |
Cumulative growth
Daily Returns
Daily percentage return beside RPRX.
Daily Out/Under-Performance
Portfolio return minus RPRX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RPRX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RPRX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling